[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Innovent Biologics Inc.
Innovent Biologics announces initial results of a Phase X study for Trispecific Antibody IBI3003 in multiple myeloma. The company also saw its Mazdutide drug mentioned as a competitor to Eli Lilly's Mounjaro in China.
About Innovent Biologics Inc.
Innovent Biologics Inc. is a biopharmaceutical company focused on developing and commercializing innovative medicines.
Insights
- Innovent Biologics Inc. creators is up XXXXX% from the previous week.
- Innovent Biologics Inc. mentions is up XX% from the previous week.
Price: $
Price 24-Hour Time-Series Raw Data
The price is experiencing upward pressure due to positive sentiment and rising engagements, supported by positive news and announcements from the company, with the price hitting an all-time high for the hour.
1-Year High: $XXX on 2025-09-03
1-Year Low: $XX on 2025-01-16
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Innovent Biologics Inc. is currently AltRank #515 based on combined combined social and market metrics
Daily Average: XXX
1-Year High: XXXXX on 2025-02-20
1-Year Low: XXX on 2025-11-07
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-02-18
1-Year Low: X on 2025-10-14
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXXXX -XXXX%
X Month: XXXXXX -XX%
X Months: XXXXXXX +448%
X Year: XXXXXXX +467%
1-Year High: XXXXXX on 2025-09-23
1-Year Low: X on 2024-12-23
Engagements by network (24h): News: X Reddit: XXX X: XX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +22%
X Month: XXX +1.90%
X Months: XXX +47%
X Year: XXX +320%
1-Year High: XXX on 2025-06-18
1-Year Low: X on 2024-12-15
Mentions by network (24h): News: X Reddit: XX X: XX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Innovent Biologics Inc. in the last XX hours which is down X% from XX in the previous XX hours
Daily Average: XX
X Week: XX +22%
X Month: XX -X%
X Months: XXX +38%
X Year: XXX +308%
1-Year High: XX on 2025-06-18
1-Year Low: X on 2024-12-15
The most influential creators that mention Innovent Biologics Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @anuj_rawat | X | X | XX | |
| @business | X | XXXXXXXXXXX | X | X |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% no change
X Months: XXX% +5%
X Year: XXX% no change
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-02-14
Most Supportive Themes:
- Drug Deal with Takeda: (60%) Innovent Biologics Inc. has entered into a significant drug deal with Takeda, involving oncology drugs and potential payments up to $XXXX billion. This partnership is seen as a major step for both companies in advancing cancer treatments.
- Mazdutide Drug Performance: (40%) Innovent Biologics Inc.'s Mazdutide drug has shown superiority in clinical trials for glycemic control and weight loss compared to Semaglutide. The drug has also received approvals in China and is showing strong early results post-launch.
Most Critical Themes:
Market Cap: $undefined
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXX on 2025-04-01
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-16
Top Innovent Biologics Inc. News
Top news links shared on social in the last XX hours
Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.
"ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase X Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma"
News Link @PRNewswire 2025-12-08T05:36Z 228.6M followers, XX engagements
"Innovent first Chinese biotech firm to market weight-loss drug joins Hang Seng Index South China Morning Post"
News Link @SCMPNews 2025-11-21T15:31Z 228.6M followers, XXX engagements
"Innovent Biologics to Join Hong Kongs Equity Benchmark Index - Bloomberg"
News Link @business 2025-11-21T10:32Z 228.6M followers, 17K engagements
Top Innovent Biologics Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Innovent Biologics achieves key milestone as PECONDLE delivers sustained efficacy in Phase X psoriasis trial #InnoventBiologics #PECONDLE #PsoriasisTreatment #Biologics #IL23 #AutoimmuneDiseases #PharmaNews #CLEAR2Trial #ChinaBiotech #QuarterlyDosing"
X Link @cricket_fundas 2025-12-09T00:26Z 1856 followers, XX engagements
"Reuters reporting $LLY s Mounjaro added to China's state insurance list for diabetes treatment Peers reacting negative due to fear of competition -Macquarie Capital analysts wrote in a note Monday that Mounjaro could take market share away from Novo $NVO (down 0.5%) and Innovent Biologics (down 7%)"
X Link @knockouttrader 2025-12-08T09:34Z XXX followers, XXX engagements
"ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase X Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma"
X Link @Innovent_2011 2025-12-08T05:36Z XXX followers, XX engagements
"Innovent Biologics Announces Closing of Global Strategic Partnership with Takeda for Next-Generation IO and ADC Therapies"
X Link @DigitalMoreco 2025-12-05T00:58Z 7831 followers, XX engagements